Eptinezumab is a medicine used to prevent chronic migraine, a type of headache that can significantly impact daily life.
| Drug class | CGRP Antibody |
|---|---|
| Type | Single |
| Forms | IV Infusion |
| Common strength | 100 / 300 mg |
| Common Indian brands | Vyepti |
| Prescription status | Prescription (hospital use) |
What Eptinezumab is used for
Eptinezumab is a specialized medicine used in the field of Neuro-Ophthalmology. It is specifically prescribed for:
- Prevention of chronic migraine
Chronic migraine is a severe type of headache that occurs frequently, often for 15 or more days a month, with at least 8 of those days involving migraine symptoms. This condition can be debilitating, affecting a person’s ability to work, study, and enjoy daily activities. By preventing these frequent and severe headaches, Eptinezumab aims to improve the quality of life for patients suffering from chronic migraine.
How it works
Eptinezumab works by targeting a specific substance in the body called Calcitonin Gene-Related Peptide (CGRP). CGRP is a protein that plays a key role in the development and experience of migraine headaches. By blocking the action of CGRP, Eptinezumab helps to reduce the frequency and severity of migraine attacks, thereby preventing chronic migraines.
How it’s used
Eptinezumab is administered as an intravenous (IV) infusion. This means the medicine is given directly into your vein, usually in your arm, through a drip. It is a treatment option that is given by healthcare professionals in a hospital or clinic setting. The typical dosing schedule for Eptinezumab is once every three months. Your ophthalmologist or neurologist will determine the appropriate strength (either 100 mg or 300 mg) and frequency of your infusions based on your specific condition and response to treatment. It is crucial to attend all your scheduled appointments for the infusion to ensure the medicine works effectively for you.
Always follow your ophthalmologist’s exact instructions.
Brands available in India
- Vyepti
Brand availability and pricing vary; confirm with your pharmacist.
Good to know
Prescription eye medicine — use only as directed by a qualified ophthalmologist. This page is for general education and is not a substitute for professional medical advice, diagnosis or a prescription. Do not self-medicate or reuse an old prescription. This is given only by specialists in a hospital or clinic setting and is never for self-use.
Precautions & side effects
As with any prescription medicine, it is important to be aware of certain precautions when using Eptinezumab:
- Eptinezumab is an intravenous (IV) preventive option for chronic migraine. This means it is given directly into a vein and is not a self-administered medication.
- This medicine is only for hospital use and must be administered by qualified healthcare professionals.
- Always use Eptinezumab strictly as directed by your qualified ophthalmologist or neurologist.
- This page provides general information and should not be considered a substitute for professional medical advice, diagnosis, or a prescription.
- Do not attempt to self-medicate or reuse an old prescription.
- It is essential to discuss your complete medical history, including any existing health conditions or other medications you are taking, with your doctor before starting Eptinezumab.
Your doctor will monitor you during and after the infusion to ensure your safety and address any concerns.
Understanding Chronic Migraine
Chronic migraine is a neurological condition characterized by frequent and often severe headaches. Unlike occasional headaches, chronic migraine means experiencing headaches for 15 or more days per month, with at least 8 of those days having migraine features. These features can include throbbing pain, often on one side of the head, sensitivity to light, sound, or smells, and nausea or vomiting. Chronic migraine can significantly disrupt daily life, making it difficult to concentrate, work, or participate in social activities. It’s important to understand that migraine is a real medical condition, not just a ‘bad headache,’ and effective treatments like Eptinezumab are available to help manage it. Living with chronic migraine can be challenging, but with the right medical care and support, it is possible to reduce the frequency and intensity of attacks and improve your overall quality of life. Maintaining a migraine diary can be very helpful in tracking your symptoms, triggers, and the effectiveness of your treatment. This information can be valuable for your doctor in tailoring your treatment plan.
Administering Intravenous Medicines Correctly
Eptinezumab is given as an intravenous (IV) infusion, which means it is administered directly into your bloodstream through a vein, typically in your arm. This procedure is always performed by trained healthcare professionals in a hospital or clinic setting. You will be seated comfortably while a nurse or doctor inserts a small needle into your vein and connects it to an IV bag containing the medicine. The infusion usually takes a specific amount of time, during which you will be monitored. It is crucial to remain calm and follow any instructions given by the medical staff during the infusion. After the infusion, the needle will be removed, and a small dressing will be applied to the site. You may be asked to remain in the clinic for a short period for observation to ensure there are no immediate adverse reactions. Since Eptinezumab is a preventive treatment, it is vital to adhere to your scheduled appointments for infusions, typically every three months, to maintain its effectiveness. Do not miss appointments without consulting your doctor.
General Health and When to Seek Medical Help
While Eptinezumab is a powerful tool in managing chronic migraine, it’s also important to maintain overall good health practices. This includes a balanced diet, regular exercise (as advised by your doctor, especially if you have chronic pain), adequate sleep, and stress management techniques. These lifestyle factors can complement your medical treatment and contribute to better migraine control. Always keep an open line of communication with your ophthalmologist or neurologist. If you experience any new or worsening symptoms, unusual side effects during or after the infusion, or if your migraines do not seem to be improving, contact your doctor immediately. Do not wait for your next scheduled appointment if you have significant concerns. It is also important to inform your doctor about any other medications you are taking, including over-the-counter drugs, supplements, or herbal remedies, as these can sometimes interact with Eptinezumab. Regular follow-up appointments are essential to monitor your progress and adjust your treatment plan if necessary. Remember, your healthcare team at Pristine Eye Hospitals is here to support you in your journey towards better health and migraine management.
Frequently asked questions
What is Eptinezumab used for?
Eptinezumab is used for the prevention of chronic migraine, a type of severe and frequent headache.
How does Eptinezumab work?
Eptinezumab works by blocking Calcitonin Gene-Related Peptide (CGRP), a substance in the body that plays a key role in causing migraine headaches.
What are the common Indian brands for Eptinezumab?
In India, Eptinezumab is available under the brand name Vyepti.
How is Eptinezumab administered?
Eptinezumab is given as an intravenous (IV) infusion, meaning it is administered directly into a vein by healthcare professionals in a hospital or clinic setting. It is typically given once every three months.
Do I need a prescription for Eptinezumab?
Yes, Eptinezumab is a prescription medicine and is only administered by specialists in a hospital or clinic setting. It is never for self-use.
What are the key precautions to keep in mind while using Eptinezumab?
Eptinezumab is an IV preventive option for chronic migraine and must be used only as directed by a qualified ophthalmologist or neurologist. It is for hospital use only and never for self-medication. Always discuss your full medical history with your doctor.
References
- A Review of Eptinezumab Use in Migraine – PMC
- Eye health – MedlinePlus (US National Library of Medicine)
- Eye health information – American Academy of Ophthalmology
- Learn about eye health – National Eye Institute (NIH)
- Blindness and vision impairment – World Health Organization
Medically reviewed by Dr. C Jagadesh Reddy, Chief Surgeon: Cornea, Cataract and Refractive Surgery — last reviewed 2026-07-28.
This page is for general education only and is not a substitute for professional medical advice, diagnosis or treatment. Never self-medicate or reuse an old prescription. Always consult a qualified ophthalmologist before starting, changing or stopping any eye medicine.